EGF and hepatocellular carcinoma: Notably, CNK1 promotes insulin-dependent activation of ARF1 and ARF6 in hepatocellular carcinoma cells15, while IPCEF1 overexpression enhances ARF6 activity in EGF-stimulated COS cells16.